Product Images Erlotinib Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Erlotinib Hydrochloride NDC 72205-080 by Novadoz Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

100-mg-carton-label - 100 mg carton label

100-mg-carton-label - 100 mg carton label

The text is not readable and appears to be garbled output. Therefore, the description cannot be generated.*

100-mg-cntr-label - 100 mg cntr label

100-mg-cntr-label - 100 mg cntr label

This text appears to be a medication label that provides information about the medication name, dosage, storage, manufacturers, and distributors. The medication is called "ficosted tablet" and contains 100mg of el with the Fe base. The label provides guidance on the usual dosage and storage temperature. It is produced by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals in New Jersey. The label also cautions users to keep the medication out of the reach of children.*

150-mg-carton-label - 150 mg carton label

150-mg-carton-label - 150 mg carton label

This is a prescription drug called Erlotinib Tablets, manufactured by MSN Laboratories in India and distributed in the US by Novadoz Pharmaceuticals LLC. The tablets come in a bottle of 30 and contain 150mg of Erlotinib Hydrochloride. The usual dosage and storage instructions are provided in the enclosed package insert. This medicine is only available with a prescription and should be kept out of the reach of children.*

150-mg-cntr-label - 150 mg cntr label

150-mg-cntr-label - 150 mg cntr label

25-mg-carton-label - 25 mg carton label

25-mg-carton-label - 25 mg carton label

25-mg-cntr-label - 25 mg cntr label

25-mg-cntr-label - 25 mg cntr label

srt - erlotinib structure

srt - erlotinib structure

HCI stands for Human-Computer Interaction, which refers to the study and design of interfaces between people and technology. It encompasses the process of designing user interfaces, evaluating the usability of systems, and studying the behavior of users interacting with technology. HCI is a multidisciplinary field that draws on expertise from computer science, psychology, design, engineering, and other areas to create technology that is effective, efficient, and enjoyable to use.*

fig-1 - figure 1

fig-1 - figure 1

fig-2 - figure 2

fig-2 - figure 2

This appears to be a survival probability chart, showing the overall survival rate in months for two different treatment groups (placebo and Erlotinib), as well as the number of patients at risk for each month. It is unclear what condition or disease the treatments are being used for.*

fig-3 - figure 3

fig-3 - figure 3

fig-4 - figure 4

fig-4 - figure 4

This is a graph or a chart that represents the survival probability of patients who received either placebo or erlotinib for overall survival (in months). The graph shows the number of patients at risk for both treatments at different time intervals (in months) from 0 to 39. The has also captured some of the numerical values in the graph.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.